A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Doxacurium
Nitroaspirin
The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Obeticholic acid.
Doxacurium
Ifetroban
The risk or severity of adverse effects can be increased when Ifetroban is combined with Obeticholic acid.
Doxacurium
Sarpogrelate
The risk or severity of adverse effects can be increased when Sarpogrelate is combined with Obeticholic acid.
Doxacurium
Naftopidil
The risk or severity of adverse effects can be increased when Naftopidil is combined with Obeticholic acid.
Doxacurium
Trapidil
The risk or severity of adverse effects can be increased when Trapidil is combined with Obeticholic acid.
Doxacurium
Vorapaxar
The risk or severity of adverse effects can be increased when Vorapaxar is combined with Obeticholic acid.
Doxacurium
Icosapent ethyl
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Obeticholic acid.
Doxacurium
Ticagrelor
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Obeticholic acid.
Doxacurium
Triflusal
The risk or severity of adverse effects can be increased when Triflusal is combined with Obeticholic acid.
Doxacurium
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Obeticholic acid.
Doxacurium
Cangrelor
The risk or severity of adverse effects can be increased when Cangrelor is combined with Obeticholic acid.
Doxacurium
Prasugrel
The risk or severity of adverse effects can be increased when Prasugrel is combined with Obeticholic acid.
Doxacurium
Caplacizumab
The risk or severity of adverse effects can be increased when Caplacizumab is combined with Obeticholic acid.
Doxacurium
Andrographolide
The risk or severity of adverse effects can be increased when Andrographolide is combined with Obeticholic acid.
Doxacurium
Ibudilast
The risk or severity of adverse effects can be increased when Ibudilast is combined with Obeticholic acid.
Doxacurium
Beraprost
The risk or severity of adverse effects can be increased when Beraprost is combined with Obeticholic acid.
Doxacurium
Defibrotide
The risk or severity of adverse effects can be increased when Defibrotide is combined with Obeticholic acid.
Doxacurium
Tesmilifene
The risk or severity of adverse effects can be increased when Tesmilifene is combined with Obeticholic acid.
Doxacurium
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Obeticholic acid.
Doxacurium
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Obeticholic acid.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3